[1]
KATSITADZE, T. et al. 2025. THE IL-17 FAMILY OF CYTOKINES IMMUNOLOGICAL AND IMMUNOPATHOLOGICAL ASPECTS, PSORIASIS TREATMENT WITH IL-17 INHIBITOR – SECUKINUMAB. Experimental and Clinical Medicine Georgia. 1 (Mar. 2025), 132–137. DOI:https://doi.org/10.52340/jecm.2025.01.27.